Variation in human metabolism of arsenic

被引:49
作者
Vahter, M [1 ]
机构
[1] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden
来源
ARSENIC EXPOSURE AND HEALTH EFFECTS | 1999年
关键词
arsenic methylation; polymorphism; dose level; age and gender;
D O I
10.1016/B978-008043648-7/50031-5
中图分类号
P3 [地球物理学]; P59 [地球化学];
学科分类号
0708 ; 070902 ;
摘要
Inorganic arsenic is methylated to methylarsonic acid (MMA) and dimethylarsinic acid (DMA) by alternating reduction of AsV to AsIII and addition of a methyl group from S-adenosylmethionine. The methylated metabolites are less reactive with tissue constituents and more readily excreted in the urine than is inorganic arsenic. Therefore, a low percentage of MMA + DMA in urine correlates with a low rate of excretion of the absorbed arsenic. Although most studies indicate on average 10-30% inorganic arsenic, 10-20% MMA, and 60-70% DMA in urine, there seems to be a polymorphism in arsenic methylation. Our studies on arsenic-exposed native Andean people in north-west Argentina, show only a few percent MMA in the urine, which in most other populations is a rare event, occurring in a few individuals only. However, in several other mammalian species this is a common feature. On the other hand, one study indicates a higher than usual % MMA in the urine of arsenic exposed people in Taiwan. There is also a marked intra-individual variation in the urinary pattern of arsenic metabolites. In experimental studies we have shown that the methylation of arsenic is influenced by the form of arsenic absorbed, the dose level, route of exposure, and nutritional status. Our studies in Argentina indicate that arsenic methylation is influenced by age, dose level and, probably, hormonal status. For example, in children there was a lower % DMA in urine compared to adults, and an increasing % DMA with increasing exposure level.
引用
收藏
页码:267 / 279
页数:7
相关论文
共 97 条
[1]   Human histamine N-methyltransferase gene: Structural characterization and chromosomal localization [J].
Aksoy, S ;
Raftogianis, R ;
Weinshilboum, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (02) :548-554
[2]   Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity [J].
Aposhian, HV .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :397-419
[3]  
APOSHIAN HV, 1997, ARSENIC EXPOSURE HLT, V2, P296
[4]   ARSENIC BINDING-PROTEINS OF MAMMALIAN SYSTEMS .1. ISOLATION OF 3 ARSENITE-BINDING PROTEINS OF RABBIT LIVER [J].
BOGDAN, GM ;
SAMPAYOREYES, A ;
APOSHIAN, HV .
TOXICOLOGY, 1994, 93 (2-3) :175-193
[5]   ARSENIC IN DRINKING-WATER OF CITY OF ANTOFAGASTA - EPIDEMIOLOGICAL AND CLINICAL-STUDY BEFORE AND AFTER INSTALLATION OF A TREATMENT-PLANT [J].
BORGONO, JM ;
VICENT, P ;
VENTURINO, H ;
INFANTE, A .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1977, 19 (AUG) :103-105
[6]   INCREASED NEUROTOXICITY OF ARSENIC IN METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY [J].
BROUWER, OF ;
ONKENHOUT, W ;
EDELBROEK, PM ;
DEKOM, JFM ;
DEWOLFF, FA ;
PETERS, ACB .
CLINICAL NEUROLOGY AND NEUROSURGERY, 1992, 94 (04) :307-310
[7]  
BUCHET JP, 1980, INT ARCH OCC ENV HEA, V46, P11, DOI 10.1007/BF00377456
[8]   URINARY-EXCRETION OF INORGANIC ARSENIC AND ITS METABOLITES AFTER REPEATED INGESTION OF SODIUM METAARSENITE BY VOLUNTEERS [J].
BUCHET, JP ;
LAUWERYS, R ;
ROELS, H .
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1981, 48 (02) :111-118
[9]   STUDY OF INORGANIC ARSENIC METHYLATION BY RAT-LIVER INVITRO - RELEVANCE FOR THE INTERPRETATION OF OBSERVATIONS IN MAN [J].
BUCHET, JP ;
LAUWERYS, R .
ARCHIVES OF TOXICOLOGY, 1985, 57 (02) :125-129
[10]   ROLE OF THIOLS IN THE INVITRO METHYLATION OF INORGANIC ARSENIC BY RAT-LIVER CYTOSOL [J].
BUCHET, JP ;
LAUWERYS, R .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (16) :3149-3153